These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 34521792)
1. [Consideration on Expiration Days Setting for the Introduction of Drug Vial Optimization]. Hama K; Hirabatake M; Ikesue H; Muroi N; Hashida T Gan To Kagaku Ryoho; 2021 Sep; 48(9):1139-1143. PubMed ID: 34521792 [TBL] [Abstract][Full Text] [Related]
2. Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital. Matsuo K; Nomura H; Uchiyama M; Miyazaki M; Imakyure O BMC Health Serv Res; 2020 Nov; 20(1):1017. PubMed ID: 33167996 [TBL] [Abstract][Full Text] [Related]
3. [Drug Vial Optimization(DVO)for Anti-Cancer Drugs]. Iwamoto T Gan To Kagaku Ryoho; 2017 May; 44(5):353-356. PubMed ID: 28536326 [TBL] [Abstract][Full Text] [Related]
4. Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial Optimization for Cost Savings. Fukudo M; Ishikawa R; Mishima K; Ono T; Matsumoto S; Tasaki Y JCO Oncol Pract; 2020 Oct; 16(10):e1134-e1142. PubMed ID: 32496875 [TBL] [Abstract][Full Text] [Related]
5. Vial Sharing of High-Cost Drugs to Decrease Leftovers and Costs: A Retrospective Observational Study on Patisiran Administration in Bologna, Italy. Cozzio M; Melis A; La Fauci G; Guaraldi P; Caputo R; Lioi F; Cellini GS; Santilli G; Scarlattei D; Siravo P; Zuccheri P; Ziglio A; Montalti M Healthcare (Basel); 2023 Apr; 11(7):. PubMed ID: 37046940 [TBL] [Abstract][Full Text] [Related]
6. [Examination of Actual Medical Material Cost and Cost Reduction Related to Exposure Prevention in the Preparation of Anticancer Drugs]. Moriya A; Usami E; Hirose T; Takenaka S; Asano H; Okada K; Adachi S; Yoshimura T Gan To Kagaku Ryoho; 2019 Aug; 46(8):1281-1286. PubMed ID: 31501370 [TBL] [Abstract][Full Text] [Related]
7. Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation. Adade CA; Benabbes M; Belahcen MJ; Rahali Y J Oncol Pharm Pract; 2020 Oct; 26(7):1630-1636. PubMed ID: 32046581 [TBL] [Abstract][Full Text] [Related]
8. Cost of discarded medication in Indiana long-term care facilities. Brown CH; Kirk KW Am J Hosp Pharm; 1984 Apr; 41(4):698-702. PubMed ID: 6720712 [TBL] [Abstract][Full Text] [Related]
9. [Economic Loss of Remaining Contents in Molecular Target Drug Preparation and the Simulation for Cost Saving]. Usami E; Kimura M; Fukuoka T; Okada K; Yoshimura T Gan To Kagaku Ryoho; 2016 Jun; 43(6):743-7. PubMed ID: 27306812 [TBL] [Abstract][Full Text] [Related]
10. Are drugs that have passed their expiration dates OK to use, or should they be discarded? Johns Hopkins Med Lett Health After 50; 2014 Mar; 26(1):7. PubMed ID: 24937850 [No Abstract] [Full Text] [Related]
11. [A Survey to Compare the Specifications and Stability of Anticancer Drugs in Japan, the United States, Canada, and Australia]. Matsuyama C; Suzuki S; Gilbar PJ; Yamaguchi M Gan To Kagaku Ryoho; 2018 Sep; 45(9):1327-1334. PubMed ID: 30237375 [TBL] [Abstract][Full Text] [Related]
12. [Wasted Anti-Cancer Agents Due to Cancellations after Dispensing]. Fukuda M; Honda T; Uchida T; Nose S; Kodama Y; Hashizume J; Tsuchiya A; Matsuo K; Kamada M; Honda K; Ishii K; Yamaguchi H; Mukae H; Ashizawa K Gan To Kagaku Ryoho; 2022 Aug; 49(8):861-865. PubMed ID: 36046971 [TBL] [Abstract][Full Text] [Related]
13. Optimal vial sizes for infliximab injection: a simulation study of Japanese demographic data. Nakamura N; Kusumoto M; Yano Y Int J Pharm Pract; 2021 Aug; 29(4):344-349. PubMed ID: 33881507 [TBL] [Abstract][Full Text] [Related]
14. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
15. Costs and implications of discarded medication in hospice. Speer ND; Dioso J; Casner PR J Palliat Med; 2013 Aug; 16(8):975-8. PubMed ID: 23802130 [TBL] [Abstract][Full Text] [Related]
16. Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage. Yamada H; Kobayashi R; Shimizu S; Yamada Y; Ishida M; Shimoda H; Kato-Hayashi H; Fujii H; Iihara H; Tanaka H; Suzuki A Int J Clin Pract; 2020 Apr; 74(4):e13464. PubMed ID: 31830345 [TBL] [Abstract][Full Text] [Related]
17. The impact of patent expiry on drug prices: insights from the Dutch market. van der Schans S; Vondeling GT; Cao Q; van der Pol S; Visser S; Postma MJ; Rozenbaum MH J Mark Access Health Policy; 2020 Dec; 9(1):1849984. PubMed ID: 33312457 [No Abstract] [Full Text] [Related]
18. Are significant numbers of abnormal cells lost on the discarded ThinPrep® broom when used for cervical cytology? Umana A; Dunsmore H; Herbert A; Jokhan A; Kubba A Cytopathology; 2013 Aug; 24(4):228-34. PubMed ID: 23171273 [TBL] [Abstract][Full Text] [Related]
19. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume. Hladik B; Buscke F; Frost R; Rothhaar U PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482 [TBL] [Abstract][Full Text] [Related]
20. Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate Cancer. Jiang DM; Fallah-Rad N; Lee R; Ng P; Smith AD; Hansen AR; Joshua AM; Beca J; Sridhar SS Eur Urol; 2021 Feb; 79(2):177-179. PubMed ID: 33461737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]